| 【Company Research】Yum China (9987 HK) – Headwinds linger despite faster expansion |
| 【Company Research】I-Mab BioPharma (IMAB US) – Partnership with Sinopharm to prepare for commercialization in China |
| 【Company Research】Goldwind (2208 HK) – 3Q21 results slight beat; wind farm disposal to sustain earnings performance in 2022 |
| 【Company Research】China Longyuan (916 HK) – Backdoor listing on track; 4Q21 performance to sustain good momentum |
| 【Company Research】Zhejiang Dingli - A (603338 CH) – 3Q21 net profit +5.4% YoY; in line with expectation |
| 【公司研究】永达汽车 (3669 HK) – 抛弃偏见，拥抱重估 |
| 【Company Research】Ping An (2318 HK) – Slower 3Q21 momentum |
| 【Company Research】Shengyi Technology (600183 CH) – Solid 3Q21; Cost pressure ahead |
| 【Sector Research】China Software & IT Services – Property weakness may slow digitalization pace |
| 【Company Research】Meituan (3690 HK) – Looking beyond 3Q21E epidemic impact |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
